Core Viewpoint - HeartSciences Inc. has partnered with Cibolo Rural Health Networks to provide its MyoVista Insights™ ECG management platform to a network of 123 independent hospitals, enhancing ECG workflow efficiency and clinical decision-making [1][2][4]. Group 1: Company Overview - HeartSciences is a healthcare information technology company focused on advancing electrocardiography through artificial intelligence integration [1][5]. - The MyoVista Insights platform is a cloud-native ECG management system designed to improve clinical efficiency and decision-making [5]. Group 2: Partnership Details - Cibolo Health has selected MyoVista Insights as its endorsed ECG management platform for its network of independent hospitals across six states [2][4]. - The collaboration aims to modernize legacy ECG workflows, allowing physicians to interpret ECGs more quickly and efficiently [2][4]. Group 3: Technology and Benefits - MyoVista Insights provides secure, cloud-based ECG data management across various devices and file formats, supporting the integration of AI-ECG algorithms into clinical practice [3]. - The partnership aligns with Cibolo Health's mission to enhance care quality and operational efficiency while managing costs for its member hospitals [4][6].

As filed with the Securities and Exchange Commission on January 8, 2026 Registration No. 333-______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCWORX CORP. (Exact Name of Registrant As Specified In Its Charter) Delaware 7374 47-5412331 (State Or Other Jurisdiction Of Incorporation Or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 35 VILLAGE RD., SUITE ...

Core Viewpoint - HeartSciences Inc. is advancing its MyoVista Insights™ healthcare IT platform and has submitted its MyoVista® wavECG™ device for FDA clearance, marking significant progress in the commercialization of its ECG technology [1][2][5]. Group 1: Business Developments - The Company has made substantial advancements in the commercialization of its MyoVista Insights™ platform and has submitted the MyoVista® wavECG™ device to the FDA for 510(k) premarket clearance [2][5]. - MyoVista Insights is classified as a Medical Device Data System (MDDS), which allows for a faster and less costly commercial rollout compared to regulated medical devices [7]. - The platform has received strong validation from early adopters and is currently in commercial discussions with several healthcare institutions, with expectations to announce key customer wins soon [5][7]. Group 2: Financial Results - HeartSciences reported no meaningful revenue for the fiscal second quarter ended October 31, 2025, and had approximately $2.0 million in cash and cash equivalents, along with $4.2 million in shareholders' equity [8]. Group 3: Market Opportunity - The MyoVista Insights platform is designed to host third-party AI-ECG algorithms, positioning the Company to capture a multibillion-dollar market opportunity while reducing costs and time for algorithm development and regulatory clearance [7]. - The Company plans to host an investor call early in the new year to demonstrate the MyoVista Insights software and discuss its commercialization strategy and market opportunity [7].

Core Insights - HeartSciences Inc. has submitted its MyoVista® wavECG™ device to the FDA for 510(k) premarket clearance, marking a significant regulatory milestone in its commercialization strategy [1][2] Company Overview - HeartSciences is a healthcare information technology company focused on enhancing ECG/EKG usage through artificial intelligence integration [3] - The MyoVista Insights platform is a next-generation ECG management system designed to improve clinical efficiency and decision-making [3] Product Details - The MyoVista wavECG device offers conventional ECG functionality and is capable of hosting AI-ECG algorithms [2] - The company has opted to separate the FDA submissions for the MyoVista wavECG device and its AI-ECG software algorithm to align with updated clinical standards and expedite the regulatory review process [2] Strategic Developments - The separation of submissions is intended to simplify the regulatory pathway and accelerate device clearance while allowing for future deployment of the AI-ECG algorithm across multiple platforms [2] - The company is making progress with its MyoVista Insights platform and is engaged in commercial discussions with healthcare institutions, expecting to announce initial customer deployments soon [2]

Core Insights - Nationwide access to validated Oregon POLST forms is now enabled by MyDirectives and HIT Commons in participating EHR workflows [1] Group 1 - MyDirectives and HIT Commons have collaborated to provide access to Oregon POLST forms across the nation [1] - The integration allows for improved workflows within electronic health records (EHR) systems [1]

Core Points - The National Medical Insurance Administration has launched a nationwide medical insurance imaging cloud service to address issues faced by patients seeking medical care across provinces, such as difficulties in accessing and transferring medical imaging results [1][3] - The initiative aims to reduce redundant examinations and alleviate the burden on patients by allowing medical institutions to access imaging data from other designated facilities [1][3] Group 1 - The medical imaging cloud construction began in December 2024, enabling the upload of CT, MRI, and X-ray images to a cloud storage system, which can be accessed for free via mobile devices [3] - The establishment of a national medical imaging cloud data network will facilitate patient access, peer review, and insurance verification, addressing the challenges of redundant examinations [3][8] - Shenzhen has initiated a medical imaging cloud data sharing center, allowing insured individuals to access imaging data with a single click and eventually view data from other pilot cities [4] Group 2 - The storage and transmission of original imaging data require significant resources, and the National Medical Insurance Administration's initiative addresses three major challenges in cross-province data retrieval [6] - Currently, 24 provinces have completed the deployment of medical imaging cloud software, with 170 million indexed imaging data entries collected at the national platform [8] - The successful construction of the cloud platform will enable the sharing of clinical and examination data, reducing the need for repeated examinations for chronic conditions [10] Group 3 - Technological advancements are transforming diagnostic and treatment models, allowing for rapid access to high-quality imaging data and enabling doctors to track disease progression effectively [12] - The National Medical Insurance Administration plans to accelerate the construction of the medical insurance cloud and expand the scope of cross-province imaging data sharing, aiming for a unified national medical imaging cloud by the end of 2027 [14]

Group 1 - The article does not provide any specific content related to a company or industry [1]

Core Insights - Nanox has agreed to acquire VasoHealthcare IT to expedite the deployment of AI solutions in US healthcare facilities [1] - The acquisition is expected to enhance Nanox's operational capabilities and customer support infrastructure [2][4] Group 1: Acquisition Details - The acquisition will be completed within weeks, subject to certain conditions [1] - The total consideration for the acquisition is up to $800,000, including a $200,000 cash payment at closing and up to $600,000 in performance-based earnouts over two years [4] Group 2: VHC IT's Role - VHC IT provides essential services such as medical imaging support, data migration, systems integration, user training, and workflow optimization for healthcare providers [2] - The integration of VHC IT's infrastructure with Nanox.AI's FDA-approved solutions aims to ease adoption and accelerate deployment [3] Group 3: Strategic Implications - The acquisition is expected to assist in Nanox's commercial expansion in the US by leveraging VHC IT's expertise and customer relationships [4] - Nanox's CEO emphasized the importance of controlling the customer experience to enhance deployment pace and implementation quality [5]

Core Insights - Nanox Imaging Ltd is set to release its quarterly earnings on November 20, 2025, with Wall Street expecting an EPS of -$0.175 and revenue of approximately $3.5 million [1][6] - The company has announced an agreement to acquire VasoHealthcare IT Inc. to enhance the rollout of its AI solutions in U.S. healthcare facilities [2][6] - Despite facing financial challenges, including a negative P/E ratio of -3.49, Nanox maintains a strong liquidity position with a current ratio of 4.19 [3][5][6] Financial Metrics - The price-to-sales ratio stands at 16.35, indicating high investor expectations for future growth despite current earnings difficulties [3] - The enterprise value to sales ratio is 12.82, while the enterprise value to operating cash flow ratio is -3.98, reflecting negative operating cash flow [4] - The company has a low debt-to-equity ratio of 0.05, suggesting minimal reliance on debt financing [5]

Core Insights - Huron has acquired the payor consulting services division of AXIOM Systems, enhancing its capabilities in the payor ecosystem [1] Company Summary - The acquisition allows Huron to expand its service offerings in healthcare information technology, particularly in core administration systems and digital transformation for payors and payor-provider organizations [1] - Mark Hussey, the chief executive, expressed enthusiasm about integrating AXIOM's consulting services team into Huron [1]